XML 89 R72.htm IDEA: XBRL DOCUMENT v3.25.0.1
Segment Information - Schedule of Segment Reporting Information (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Segment Reporting, Revenue Reconciling Item [Line Items]      
Total revenue $ 114,701 $ 0 $ 0
Interest income (1,779) (1,997) (1,583)
Interest expense 11,517 13,511 13,880
Other income, net (14,022) (15,456) (1,512)
Income tax expense 893 0 0
Segment net loss (56,528) (179,817) (229,378)
Reporting Segment      
Segment Reporting, Revenue Reconciling Item [Line Items]      
Total revenue 114,701 0 0
Seralutinib 129,247 103,158 63,048
Other segment items 45,373 80,601 155,545
Interest income (1,779) (1,997) (1,583)
Interest expense 11,517 13,511 13,880
Other income, net (14,022) (15,456) (1,512)
Income tax expense 893 0 0
Segment net loss $ (56,528) $ (179,817) $ (229,378)